Erica L. Monaco - Jul 1, 2022 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Chief Executive Officer
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Erica L. Monaco
Stock symbol
BFRI
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/19/2022, 08:11 AM
Previous filing
May 26, 2022
Next filing
May 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFRI Common Stock Options Exercise +56.7K 56.7K Jul 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Restricted Stock Units Options Exercise $0 -56.7K -27.08% $0.00 153K Jul 1, 2022 Common Stock 56.7K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units covert into common stock on a one-for-one basis.
F2 On December 9, 2021, the reporting person was granted 56,689 restricted stock units, vesting on the six-month anniversary of the grant date.